Cardiac device infection: Review based on the experience of a single center

Revista Portuguesa de Cardiologia (English Edition) - Tập 35 - Trang 351-358 - 2016
Andreia Fernandes1, Miryan Cassandra1, Joana Trigo1, José Nascimento1, Maria Carmo Cachulo1, Rui Providência1, Marco Costa1, Lino Gonçalves1
1Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra – Hospital Geral, Coimbra, Portugal

Tài liệu tham khảo

Greenspon, 2011, 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States, JACC, 58, 1001, 10.1016/j.jacc.2011.04.033 Athan, 2012, Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, JAMA, 307, 1727, 10.1001/jama.2012.497 Cunningham, 2011 Murdoch, 2009, Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study, Arch Intern Med, 169, 463, 10.1001/archinternmed.2008.603 Rodriguez, 2013, Management of cardiac device-related infections: a review of protocol-driven care, Int J Cardiol, 166, 55, 10.1016/j.ijcard.2011.09.071 Deharo, 2012, Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study, Heart, 98, 724, 10.1136/heartjnl-2012-301627 Victor, 1999, Pacemaker lead infection: echocardiographic features, management, and outcome, Heart, 81, 82, 10.1136/hrt.81.1.82 Kleemann, 2010, Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibrillator patients without signs of infection undergoing generator replacement or lead revision, Europace, 12, 58, 10.1093/europace/eup334 Prutkin, 2014, Rates of and factors associated with infection in 200909 Medicare implantable cardioverter-defibrillator implants: results from the national cardiovascular data registry, Circulation, 130, 1037, 10.1161/CIRCULATIONAHA.114.009081 Romeyer-Bouchard, 2010, Prevalence and risk factors related to infections of cardiac resynchronization therapy devices, Eur Heart J, 31, 203, 10.1093/eurheartj/ehp421 Edelstein, 2009, Cardiac device-related endocarditis: epidemiology, pathogenesis, diagnosis and treatment – a review, Int J Angiol, 18, 167, 10.1055/s-0031-1278347 Baddour, 2010, Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association, Circulation, 121, 458, 10.1161/CIRCULATIONAHA.109.192665 Tarakji, 2013, How to diagnose and manage patients with cardiac implantable electronic device infections, J Arrhythm, 6, 320, 10.1016/j.joa.2013.06.001 Greenspon, 2012, Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis. Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort), JACC, 29, 681, 10.1016/j.jacc.2011.11.011 Dababneh, 2011, Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management, Cleve Clin J Med, 8, 529, 10.3949/ccjm.78a.10169 Palmisano, 2013, Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy, Europace, 15, 531, 10.1093/europace/eus337 Koutentakis, 2014, Surgical management of cardiac implantable electronic device infections, J Thorac Dis, 11, 173 Baman, 2009, Risk factors for mortality in patients with cardiac device-related infection, Circ Arrhythm Electrophysiol, 2, 129, 10.1161/CIRCEP.108.816868 Lekkerkerker, 2009, Risk factors and time delay associated with cardiac device infections: Leiden Device Registry, Heart, 95, 715, 10.1136/hrt.2008.151985 Sohail, 2007, Risk factor analysis of permanent pacemaker infection, Clin Infect Dis, 45, 166, 10.1086/518889 Klug, 2007, Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study, Circulation, 116, 1349, 10.1161/CIRCULATIONAHA.106.678664 Muers, 1981, Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trial, Br Heart J, 46, 539, 10.1136/hrt.46.5.539 Da Costa, 1998, Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis, Circulation, 97, 1796, 10.1161/01.CIR.97.18.1796 De Oliveira, 2009, Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial, Circ Arrhythm Electrophysiol, 2, 29, 10.1161/CIRCEP.108.795906 Bluhm, 1986, Antibiotic prophylaxis in pacemaker surgery: a prospective double blind trial with systemic administration of antibiotic versus placebo at implantation of cardiac pacemakers, Pacing Clin Electrophysiol, 9, 720, 10.1111/j.1540-8159.1986.tb05421.x Darouiche, 2012, Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery, Pacing Clin Electrophysiol, 35, 1348, 10.1111/j.1540-8159.2012.03506.x Darouiche, 2010, Chlorhexidine–alcohol versus povidone–iodine for surgical-site antisepsis, N Engl J Med, 362, 18, 10.1056/NEJMoa0810988 Sandoe, 2015, J Antimicrob Chemother, 70, 325, 10.1093/jac/dku383 Falace, 2003, Nonvalvular cardiovascular device related infections, Circulation, 108, 2015, 10.1161/01.CIR.0000093201.57771.47 Bongiorni, 2012, Microbiology of cardiac implantable electronic device infections, Europace, 14, 1334, 10.1093/europace/eus044 Viola, 2010, Nonstaphylococcal infections of cardiac implantable electronic devices, Circulation, 121, 2085, 10.1161/CIRCULATIONAHA.110.936708 Le, 2012, Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species, Am J Cardiol, 110, 1143, 10.1016/j.amjcard.2012.05.052 Habib, 2010, Recommendations for the practice of echocardiography in infective endocarditis, Eur J Echocardiogr, 11, 202, 10.1093/ejechocard/jeq004 Sarrazin, 2012, Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections, JACC, 59, 1616, 10.1016/j.jacc.2011.11.059 Nielsen, 2015, Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment, Eur Heart J, 10.1093/eurheartj/ehv060 Uslan, 2006, Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram-negative bacteremia, Clin Infect Dis, 43, 731, 10.1086/506942 Vaccarino, 2009, Pacemaker endocarditis: approach for lead extraction in endocarditis with large vegetations, Rev Bras Cir Cardiovasc, 24, 570, 10.1590/S0102-76382009000500020 Rastan, 2005, Pacemaker dependent patients with device infection—a modified approach, Eur J Cardio-thoracic Surg, 27, 1116, 10.1016/j.ejcts.2005.02.040 Pecha, 2013, Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency, Europace, 15, 1205, 10.1093/europace/eut031